# Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Article · Sean Wharton, Louis J. Aronne, Adam Stefański, Nasreen Alfaris, Andreea Ciudin, Koutaro Yokote, Bruno Halpern, Alpana P. Shukla, Chunmei Zhou, Lisa Farmer Macpherson, Sheryl Elaine Allen, Nadia N. Ahmad, Suzanne R. Klise

- Archive id: doi:10.1056/nejmoa2511774
- Published: 2025-09-16
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2511774
- PMID: 40960239
- Citations: 186
- Source URL: https://doi.org/10.1056/nejmoa2511774
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.